Directorio de personas
Luis Brieva Ruiz

Luis Brieva Ruiz

Grado: Doctor/a

973 705 367
lbrieva.lleida.ics(ELIMINAR)@gencat.cat

ResearcherID: http://www.researcherid.com/rid/C-3812-2011

Publicaciones

  • Montalban, X.; Sastre-Garriga, J.; Tintore, M.; Brieva, L.; Aymerich, F. X.; Rio, J.; Porcel, J.; Borras, C.; Nos, C.; Rovira, A.

    A single-center, randomized, double-blind, placebo-controlled study of interferon beta-1b on primary progressive and transitional multiple sclerosis.

    MULTIPLE SCLEROSIS JOURNAL 15 1195-1205. .

    [doi:10.1177/1352458509106937]

  • Purroy, Francisco; Begue, Robert; Quilez, Alejandro; Pinol-Ripoll, Gerard; Sanahuja, Jordi; Brieva, Luis; Seto, Eloisa; Isabel Gil, Maria

    Implicaciones diagnósticas del perfil de recurrencia tras un ataque isquémico transitorio.

    MEDICINA CLINICA 133 283-289. .

    [doi:10.1016/j.medcli.2008.10.065]

  • Manuel Porcel, Jose; Brieva, Luis; Antoni Schoenenberger, Joan

    Ataxia aguda transitoria por lidocaína local durante la inserción de un catéter pleural.

    ARCHIVOS DE BRONCONEUMOLOGIA 45 472-473. .

    [doi:10.1016/j.arbres.2009.01.008]

  • Purroy, Francisco; Begue, Robert; Quilez, Alejandro; Pinol-Ripoll, Gerard; Sanahuja, Jordi; Brieva, Luis; Seto, Eloisa; Gil, Maria Isabel

    The California, ABCD, and unified ABCD2 risk scores and the presence of acute ischemic lesions on diffusion-weighted imaging in TIA patients.

    STROKE 40 2229-2232. .

    [doi:10.1161/STROKEAHA.108.537969]

  • Bosma, L. V. A. E.; Kragt, J. J.; Brieva, L.; Khaleeli, Z.; Montalban, X.; Polman, C. H.; Thompson, A. J.; Tintore, M.; Uitdehaag, B. M. J.

    The search for responsive clinical endpoints in primary progressive multiple sclerosis.

    MULTIPLE SCLEROSIS JOURNAL 15 715-720. .

    [doi:10.1177/1352458509102626]

  • Brieva-Ruiz, L.; Diaz-Hurtado, M.; Matias-Guiu, X.; Marquez-Medina, D.; Tarragona, J.; Garus, F.

    Anti-Ri-associated paraneoplastic cerebellar degeneration and breast cancer: an autopsy case study.

    CLINICAL NEUROLOGY AND NEUROSURGERY 110 1044-1046. .

    [doi:10.1016/j.clineuro.2008.06.016]

  • Sanahuja, J.; Ordonez-Palau, S.; Begue, R.; Brieva, L.; Boquet, D.

    Primary Sjögren Syndrome with tumefactive central nervous system involvement.

    AMERICAN JOURNAL OF NEURORADIOLOGY 29 1878-1879. .

    [doi:10.3174/ajnr.A1204]

  • Bosma, Libertje Vae; Kragt, Jolijn J.; Brieva, Luis; Khaleeli, Zhaleh; Montalban, Xavier; Polman, Chris H.; Thompson, Alan J.; Tintore, Mar; Uitdehaag, Bernard M. J.

    The search for responsive clinical endpoints in primary progressive multiple sclerosis

    MULTIPLE SCLEROSIS JOURNAL 14 22-23. .

  • Comabella, Manuel; Julia, E.; Tintore, M.; Brieva, L.; Tellez, N.; Rio, J.; Lopez, C.; Rovira, A.; Montalban, X.

    Induction of serum soluble tumor necrosis factor receptor II (sTNF-RII) and interleukin-1 receptor antagonist (IL-1ra) by interferon beta-1b in patients with progressive multiple sclerosis.

    JOURNAL OF NEUROLOGY 255 1136-1141. .

    [doi:10.1007/s00415-008-0855-1]

  • Purroy, F.; Oro, M.; Quilez, A.; Sanahuja, J.; Brieva, L.; Granes, P.

    Detection of silent peripheral arterial disease in stroke patients with a low ankle-arm index

    NEUROLOGIA 23 10-14. .

  • Riverol, M.; Sepulcre, J.; Femandez-Diez, B.; Villoslada, P.; Fernandez-Alonso, M.; Rubio, M.; Rodriguez, A.; Uccelli, A.; Brieva, L.

    Antibodies against Epstein-Barr virus and herpesvirus type 6 are associated with the early phases of multiple sclerosis.

    Journal Of Neuroimmunology 192 184-185. .

    [doi:10.1016/j.jneuroim.2007.08.010]

  • Rodriguez-Revenga, Laia; Gomez-Anson, Beatriz; Munoz, Esteban; Jimenez, Dolores; Santos, Monica; Tintore, Mar; Martin, Gisela; Brieva, Luis; Mila, Montserrat

    FXTAS in spanish patients with ataxia: support for female FMR1 premutation screening.

    MOLECULAR NEUROBIOLOGY 35 324-328. .

    [doi:10.1007/s12035-007-0020-3]

Proyectos

  • EMCOVID-19: Esclerosis Múltiple y COVID-19
  • "Registro de pacientes con esclerosis múltiple (EM) tratados con Natalizumab en España"
  • UTILIDAD DE LA REALIZACION DE SECUENCIAS DE DIFUSION Y LA DETERMINACION DE BIOMARCADORES EN EL PRONOSTICO DE LOS PACIENTES CON UN ATAQUE ISQUEMICO TRANSITORIO